Health
Breast cancer mammogram screenings should start at age 40 instead of 50, says health task force
Women should get mammograms every other year starting at age 40, according to updated recommendations from the U.S. Preventive Services Task Force (USPSTF).
This is a significant change from previous guidelines, which said women should begin biennial mammograms at age 50, but could opt to begin as young as 40.
The task force also noted that there is not sufficient evidence to “assess the balance of benefits and harms” of additional breast cancer screenings — including ultrasounds and MRIs — for women with dense breast tissue who have had an otherwise negative screening mammogram.
SOME BREAST CANCER PATIENTS COULD BE AT RISK OF ANOTHER TYPE OF CANCER, STUDY REVEALS
The USPSTF previously released these recommendations in draft form in May 2023.
Tuesday’s announcement makes the guidance official.
Women should get mammograms every other year starting at age 40, according to updated recommendations from the U.S. Preventive Services Task Force. (iStock)
Other medical groups have already been recommending mammograms starting at younger ages.
The American College of Radiology recommends starting annual screenings at age 40 for women of average risk, with earlier screenings for high-risk patients.
The American Cancer Society states that women between 40 and 44 have the option to get annual mammograms, and officially recommends that women between 45 and 54 get them every year.
ICE THERAPY SHOWN TO KILL BREAST CANCER TUMORS IN NEW STUDY: ‘IMPORTANT TECHNIQUE’
The updated guidance is in response to cancer rates rising among young people and breast cancer rates rising in particular, experts say.
Between 1990 and 2019, cancer rates among people 50 and younger have risen by 79%, according to research published in BMJ Oncology.
The previous guidance stated women should begin biennial mammograms at age 50, but could opt to begin as young as 40. (iStock)
Cancer rates for people under 50 are projected to rise by 31% by the year 2030, data shows.
Breast cancer is the second leading cause of cancer death in women, according to the American Cancer Society, with rates rising 2% each year since 2015.
AN OVERVIEW OF BREAST CANCER, SYMPTOMS TO LOOK OUT FOR, WHEN TO START THINKING ABOUT ROUTINE SCREENINGS
One in eight women will develop breast cancer in their lifetime, and each woman has a one in 40 chance of dying from the disease.
The earlier screening recommendation could save 19% more lives, the USPSTS stated.
Breast cancer is the second leading cause of cancer death in women, according to the American Cancer Society. (iStock)
Reactions to the recommendation
Dr. Michelle Specht, a breast surgeon and co-director of the Avon Comprehensive Breast Evaluation Center at Mass General Cancer Center, said she is “thrilled” that the USPSTF has finalized its recommendations for earlier screenings.
“We have seen a rise in the incidence of breast cancer in women in their 40s over the last eight years and know that starting mammography at 40 will allow us to detect cancers at a smaller size and earlier stage,” she told Fox News Digital.
“Early detection not only leads to improved survival, but an improved quality of life. As a surgeon, I am able to do smaller surgeries — and my medical oncology colleagues can deescalate treatment — when cancers are detected early.”
One in eight women will develop breast cancer in their lifetime, and each woman has a one in 40 chance of dying from the disease. (iStock)
Dr. Karen Knudsen, CEO of the American Cancer Society in Virginia, said in a statement the decision is a “critical change concerning women’s health and the fight against breast cancer,” and that it sends “a strong message to referring physicians and women that breast cancer screening should begin earlier than age 50.”
“Mammography screening is the cornerstone of our strategy to find this potentially deadly disease early, when it’s easier to treat successfully,” she said in the statement.
“Mammography screening is the cornerstone of our strategy to find this potentially deadly disease early, when it’s easier to treat successfully,” said the CEO of the American Cancer Society. (iStock)
“We are encouraged that among the reasons for the USPSTF changes in their breast cancer screening recommendations include eliminating health disparities, especially among Black women, who are 40% more likely to die of breast cancer compared with White women and have a higher risk of aggressive breast cancers at all ages,” Knudsen added.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Dr. Nancy Chan, a medical oncologist at NYU Langone Perlmutter Cancer Center, shared her reaction to the updated guidelines.
“No significant difference was found in different screening methods, i.e., DBT (digital breast tomosynthesis) versus digital mammogram,” she told Fox News Digital.
“In patients with dense breast tissue, the addition of MRI may reduce cancer risk and false positive recalls.”
If a woman has a family history of breast cancer, she should meet with her doctor to have a breast cancer risk analysis performed, a doctor said. (iStock)
In clinical practice, Chan said the majority of patients undergo annual screenings with mammograms, instead of once every two years.
“Practically, in the urban setting, most patients are already and will continue to have screening with mammogram with tomosynthesis (3D mammography),” she added.
“Each patient must consider the best screening method for their individual cancer risk, such as breast density and family history.”
If a woman has a family history of breast cancer, she should meet with her doctor to have a breast cancer risk analysis performed, Specht said.
“This risk analysis will allow their physician to tailor breast cancer screening,” she noted.
“A woman at high risk of developing breast cancer may begin prior to 40 and may do both mammograms every year, [along with] supplemental screening, such as a breast MRI.”
For more Health articles, visit www.foxnews.com/health.
Health
Experts Call It 2026’s Best Diet— ‘The Results Are Often Stunning’
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Deadly ‘superbug’ is spreading across US as drug resistance grows, researchers warn
NEWYou can now listen to Fox News articles!
A deadly, drug-resistant fungus already spreading rapidly through U.S. hospitals is becoming even more threatening worldwide, though there may be hope for new treatments, according to a new scientific review.
Candida auris (C. auris), often described as a “superbug fungus,” is spreading globally and increasingly resisting human immune systems, Hackensack Meridian Center for Discovery and Innovation (CDI) researchers said in a review published in early December.
The findings reinforce prior CDC warnings that have labeled C. auris an “urgent antimicrobial threat” — the first fungal pathogen to receive that designation — as U.S. cases have surged, particularly in hospitals and long-term care centers.
DANGEROUS SPIKE IN SUPERBUG INFECTIONS SURGES ACROSS US AS EXPERTS SHARE CAUTIONS
Approximately 7,000 cases were identified across dozens of U.S. states in 2025, according to the CDC, and it has reportedly been identified in at least 60 countries.
Candida auris is a drug-resistant fungus spreading in hospitals worldwide. (Nicolas Armer/Picture Alliance via Getty Images)
The review, published in Microbiology and Molecular Biology Reviews, helps explain why the pathogen is so difficult to contain and warns that outdated diagnostics and limited treatments lag behind. It was conducted by Dr. Neeraj Chauhan of the Hackensack Meridian CDI in New Jersey, Dr. Anuradha Chowdhary of the University of Delhi’s Medical Mycology Unit and Dr. Michail Lionakis, chief of the clinical mycology program at the National Institutes of Health.
Their findings stress the need to develop “novel antifungal agents with broad-spectrum activity against human fungal pathogens, to improve diagnostic tests and to develop immune- and vaccine-based adjunct modalities for the treatment of high-risk patients,” the researchers said in a statement.
GROWING ANTIBIOTIC CRISIS COULD TURN BACTERIAL INFECTIONS DEADLY, EXPERTS WARN
“In addition, future efforts should focus on raising awareness about fungal disease through developing better surveillance mechanisms, especially in resource-poor countries,” they added. “All these developments should help improve the outcomes and prognosis of patients afflicted by opportunistic fungal infections.”
Candida auris can survive on skin and hospital surfaces, allowing it to spread easily. (iStock)
First identified in 2009 from a patient’s ear sample in Japan, C. auris has since spread to dozens of countries, including the U.S., where outbreaks have forced some hospital intensive care units to shut down, according to the researchers.
The fungus poses the greatest risk to people who are already critically ill, particularly those on ventilators or with weakened immune systems. Once infected, about half of patients may die, according to some estimates.
FLU BY STATE: WHERE THIS SEASON’S HIGHLY CONTAGIOUS VARIANT IS SPREADING THE MOST
Unlike many other fungi, C. auris can survive on human skin and cling to hospital surfaces and medical equipment, allowing it to spread easily in healthcare settings.
“It is resistant to multiple antifungal drugs, and it tends to spread in hospital settings, including on equipment being used on immunocompromised and semi-immunocompromised patients, such as ventilators and catheters,” Dr. Marc Siegel, Fox News senior medical analyst and clinical professor of medicine at NYU Langone, previously told Fox News Digital.
Scientists say the unique cell wall structure of C. auris makes it harder to kill. (iStock)
It is also frequently misdiagnosed, delaying treatment and infection control measures.
“Unfortunately, symptoms such as fever, chills and aches may be ubiquitous, and it can be mistaken for other infections,” Siegel said.
In September, he said intense research was ongoing to develop new treatments.
Only four major classes of antifungal drugs are currently available, and C. auris has already shown resistance to many of them. While three new antifungal drugs have been approved or are in late-stage trials, researchers warn that drug development has struggled to keep pace with the fungus’s evolution.
CLICK HERE FOR MORE LIFESTYLE STORIES
Despite the sobering findings, there is still room for cautious optimism.
The fungus can cling to skin and hospital surfaces, aiding its spread. (iStock)
In separate research published in December, scientists at the University of Exeter in England discovered a potential weakness in C. auris while studying the fungus in a living-host model.
The team found that, during infection, the fungus activates specific genes to scavenge iron, a nutrient it needs to survive, according to their paper, published in the Nature portfolio journal Communications Biology in December.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Because iron is essential for the pathogen, researchers believe drugs that block this process could eventually stop infections or even allow existing medications to be repurposed.
“We think our research may have revealed an Achilles’ heel in this lethal pathogen during active infection,” Dr. Hugh Gifford, a clinical lecturer at the University of Exeter and co-author of the study, said in a statement.
New research is underway to develop better treatments and diagnostics for C. auris. (iStock)
As researchers race to better understand the fungus, officials warn that strict infection control, rapid detection and continued investment in new treatments remain critical.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Health experts emphasize that C. auris is not a threat to healthy people.
Fox News Digital has reached out to the CDI researchers and additional experts for comment.
Fox News Digital’s Angelica Stabile contributed reporting.
Health
Record-breaking flu numbers reported in New York state, sparking warnings from officials
New flu strain emerging as a severe health threat
Fox News senior medical analyst Dr. Marc Siegel joins ‘America’s Newsroom’ to warn of a new strain of the flu that is spiking hospitalizations across the country and newfound risks of medical marijuana’s link to psychosis.
NEWYou can now listen to Fox News articles!
The New York State Department of Health reported a record surge in influenza activity, with 71,123 positive flu cases recorded statewide during the week ending December 20.
Health officials said the figure represents the highest number of flu cases ever reported in a single week since influenza became a reportable disease in New York in 2004.
State health data show the weekly total reflects a 38% increase from the previous reporting period, signaling a rapidly intensifying flu season.
There have been 189,312 reported positive flu cases so far this season, while influenza-related hospitalizations rose 63% in the most recent week.
FLU BY STATE: WHERE THIS SEASON’S HIGHLY CONTAGIOUS VARIANT IS SPREADING THE MOST
New York reported the highest weekly total of cases ever recorded since influenza became reportable in 2004. (iStock)
“We are seeing the highest number of flu cases ever recorded in a single week in New York state,” Health Commissioner Dr. James McDonald said in a press release.
There have been 189,312 reported flu cases so far this season, with influenza-related hospitalizations increasing 63% in the most recent week. (iStock)
Earlier this month, the department declared influenza prevalent statewide, a designation that requires unvaccinated health care workers to wear masks in patient care settings.
SURGE IN WHOOPING COUGH CASES IN SOUTHERN STATE PROMPTS HEALTH ALERTS
Health officials continue to emphasize that vaccination remains the most effective way to prevent severe illness and hospitalization from influenza.
CLICK HERE FOR MORE HEALTH STORIES
New Yorkers who have not yet received a seasonal flu shot are still encouraged to do so, with experts saying vaccination can offer protection even later in the season.
Health officials continue to urge New Yorkers to take preventive steps, including vaccination and staying home when sick, to limit further spread. (iStock)
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
To help limit further spread, the department advises individuals experiencing flu-like symptoms — including fever, cough, sore throat, or body aches — to stay home. State health officials also recommend frequent handwashing, using hand sanitizer, and avoiding close contact with sick individuals.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
For those who become ill, officials say antiviral medications are available and are most effective when started within 48 hours of symptom onset.
Health officials also added that people at higher risk for complications should contact a health care provider promptly for evaluation and possible treatment.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The department noted that flu activity typically peaks in January, meaning case counts could continue to climb in the weeks ahead.
-
Entertainment1 week agoHow the Grinch went from a Yuletide bit player to a Christmas A-lister
-
Connecticut1 week agoSnow Accumulation Estimates Increase For CT: Here Are The County-By-County Projections
-
World7 days agoHamas builds new terror regime in Gaza, recruiting teens amid problematic election
-
Indianapolis, IN1 week agoIndianapolis Colts playoffs: Updated elimination scenario, AFC standings, playoff picture for Week 17
-
Southeast1 week agoTwo attorneys vanish during Florida fishing trip as ‘heartbroken’ wife pleads for help finding them
-
Business1 week agoGoogle is at last letting users swap out embarrassing Gmail addresses without losing their data
-
World1 week agoSnoop Dogg, Lainey Wilson, Huntr/x and Andrea Bocelli Deliver Christmas-Themed Halftime Show for Netflix’s NFL Lions-Vikings Telecast
-
World1 week agoBest of 2025: Top five defining moments in the European Parliament